
報告日期 |
報告題目 |
報告人 |
2025-04-11 |
TAF15 amyloid filaments in frontotemporal lobar degeneration |
楊芹玟 |
2025-04-11 |
Dual p38MAPK and MEK inhibition disrupts adaptive chemoresistance in mesenchymal
glioblastoma to temozolomide |
陳塏倢 |
2025-04-11 |
Metabolic profiling of glioblastoma stem cells reveals pyruvate carboxylase as a critical survival factor and potential therapeutic target |
鄭恩慈 |
2025-03-28 |
Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitis |
李珍媛 |
2025-03-21 |
Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancer |
林思蓉 |
2025-03-21 |
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer |
施姵辰 |
2025-03-14 |
Mucoadhesive chitosan microcapsules for controlled gastrointestinal delivery and oral bioavailability enhancement of low molecular weight peptides |
周義盛 |
2025-03-07 |
Prion protein promotes copper toxicity in Wilson disease |
蔣嘉翰 |